PKM and hepatocellular carcinoma: Inhibiting PFKP oligomerization and enzymatic activity, as well as preventing nuclear translocation of PKM2 and its role as a transcriptional coactivator leads to decreased glycolysis and impacts HCC cell proliferation and metastasis (Yu and Li, 2017; Guan et al., 2020).